Researchers identify SP genes as key to regeneration and partially restore regrowth
Updated
Updated · ScienceDaily · May 9
Researchers identify SP genes as key to regeneration and partially restore regrowth
3 articles · Updated · ScienceDaily · May 9
Wake Forest, Duke and Wisconsin-Madison scientists reported in PNAS that SP6 and SP8 were shared across axolotls, zebrafish and mice, with CRISPR knockouts disrupting bone regrowth.
A zebrafish-inspired viral gene therapy delivering FGF8 then promoted bone regrowth in injured mouse digits and partly rescued regeneration lost when the genes were absent.
The work is an early proof of principle for regenerative medicine aimed at human limb loss, which affects more than 1 million amputations worldwide each year.
Can scientists safely regrow human limbs without activating the therapy's known cancer-causing side effects?
Could this limb-regrowth breakthrough pave the way for a future of human enhancement technologies?
The SP Gene Revolution: Pioneering the Path to Human Limb and Organ Regrowth
Overview
The recent discovery of the SP6 and SP8 genes, known as SP genes, marks a major breakthrough in regenerative medicine. Researchers identified these genes as central regulators of limb and tissue regeneration by studying a range of species, including axolotls, zebrafish, and mice. These animals provided unique insights into how regeneration works, revealing that SP genes act as a universal key to unlocking the body’s repair abilities. This foundational understanding opens new possibilities for developing therapies that could one day help humans regrow damaged tissues and organs.